Mycosis fungoides natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
If left untreated, cutaneous T cell lymphoma may progress to develop cutaneous patches, plaque, and tumors. Depending on the extent of the lymphoma at the time of diagnosis, the prognosis may vary.
If left untreated, cutaneous T cell lymphoma may progress to develop cutaneous patches, plaque, and tumors. Depending on the extent of the lymphoma at the time of diagnosis, the prognosis may vary.
==Natural History==
==Natural History==
* Mycosis fungoides is initially an indolent lymphoma that may later develop peripheral lymphadenopathy and can finally progress to widespread visceral involvement.<ref name=radio>Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 20, 2016</ref>
* Mycosis fungoides is initially an indolent lymphoma that may later develop peripheral lymphadenopathy and can finally progress to widespread visceral involvement.<ref name="radio">Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 20, 2016</ref>
* Cutaneous T cell lymphoma is usually initially seen by dermatologists with patients presenting with skin lesions.
* Cutaneous T cell lymphoma is usually initially seen by dermatologists with patients presenting with skin lesions such as erythematous patches or plaque.
* Patients often have a history of several years of eczematous or dermatitic skin lesions before the diagnosis is finally established.
* Patients often have a history of several years of eczematous or dermatitic skin lesions before the diagnosis is finally established.
* The skin lesions then progress from the patch stage to the [[plaque]] stage to cutaneous tumors.
* The skin lesions then progress from the patch stage to the [[plaque]] stage to cutaneous tumors.
==Prognosis==
==Prognosis==
* Cutaneous T cell lymphoma is usually a slow-growing (indolent) lymphoma.<ref name= canadiancancer> Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref>
* Cutaneous T cell lymphoma is usually a slow-growing (indolent) lymphoma.<ref name="canadiancancer">Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref>
* The prognosis for people with cutaneous T cell lymphoma is based on the extent of disease and how the person responds to treatment.  
* The prognosis for people with cutaneous T cell lymphoma is based on the extent of disease and how the person responds to treatment.  
* Although more advanced stages of cutaneous T cell lymphoma may not be cured, the lymphoma can still be controlled with treatment.
* Although more advanced stages of cutaneous T cell lymphoma may not be cured, the lymphoma can still be controlled with treatment.
Line 23: Line 23:


==Staging==
==Staging==
The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.<ref name= canadiancancer> Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref> Staging for cutaneous T cell lymphoma  is provided in the following table:
The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.<ref name="canadiancancer">Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref> Staging for cutaneous T cell lymphoma  is provided in the following table:


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
|+ '''Staging of cutaneous T cell lymphoma <ref name= canadiancancer> Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref>'''
|+ '''Staging of cutaneous T cell lymphoma <ref name="canadiancancer">Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016</ref>'''
! style="background: #4479BA; color:#FFF;" | Stage
! style="background: #4479BA; color:#FFF;" | Stage
! style="background: #4479BA; color:#FFF;" | Involvement
! style="background: #4479BA; color:#FFF;" | Involvement
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage I'''
| colspan="3" style="padding: 5px 5px; background: #DCDCDC;" | '''stage I'''
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | I A
| style="padding: 5px 5px; background: #F5F5F5;" | I A
Line 40: Line 40:
* 10% or more of the skin is covered with patches or plaques
* 10% or more of the skin is covered with patches or plaques
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage II'''
| colspan="3" style="padding: 5px 5px; background: #DCDCDC;" | '''stage II'''
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | II A
| style="padding: 5px 5px; background: #F5F5F5;" | II A
Line 52: Line 52:
* Lymph nodes may or may not be enlarged and do not contain cancer
* Lymph nodes may or may not be enlarged and do not contain cancer
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage III'''
| colspan="3" style="padding: 5px 5px; background: #DCDCDC;" | '''stage III'''
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | III
| style="padding: 5px 5px; background: #F5F5F5;" | III
Line 60: Line 60:
* Lymph nodes may or may not be enlarged and do not contain cancer
* Lymph nodes may or may not be enlarged and do not contain cancer
|-  
|-  
| style="padding: 5px 5px; background: #DCDCDC;" colspan=3 | '''stage IV'''
| colspan="3" style="padding: 5px 5px; background: #DCDCDC;" | '''stage IV'''
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | IV A
| style="padding: 5px 5px; background: #F5F5F5;" | IV A
Line 71: Line 71:
* Lymph nodes may be enlarged and may contain cancer
* Lymph nodes may be enlarged and may contain cancer
|}
|}


==References==
==References==

Revision as of 15:55, 30 October 2018

Cutaneous T cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Mycosis fungoides
Sezary syndrome

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

If left untreated, cutaneous T cell lymphoma may progress to develop cutaneous patches, plaque, and tumors. Depending on the extent of the lymphoma at the time of diagnosis, the prognosis may vary.

Natural History

  • Mycosis fungoides is initially an indolent lymphoma that may later develop peripheral lymphadenopathy and can finally progress to widespread visceral involvement.[1]
  • Cutaneous T cell lymphoma is usually initially seen by dermatologists with patients presenting with skin lesions such as erythematous patches or plaque.
  • Patients often have a history of several years of eczematous or dermatitic skin lesions before the diagnosis is finally established.
  • The skin lesions then progress from the patch stage to the plaque stage to cutaneous tumors.

Prognosis

  • Cutaneous T cell lymphoma is usually a slow-growing (indolent) lymphoma.[2]
  • The prognosis for people with cutaneous T cell lymphoma is based on the extent of disease and how the person responds to treatment.
  • Although more advanced stages of cutaneous T cell lymphoma may not be cured, the lymphoma can still be controlled with treatment.

Favorable prognosis

  • Early stage disease
  • Lymphoma is confined to the skin

Unfavorable prognosis

  • More advanced disease
  • Lymphoma has spread to lymph nodes
  • Lymphoma has spread to other organs


Staging

The staging of cutaneous T cell lymphoma is based on skin and lymph node involvement.[2] Staging for cutaneous T cell lymphoma is provided in the following table:

Staging of cutaneous T cell lymphoma [2]
Stage Involvement
stage I
I A
  • Less than 10% of the skin is covered with patches or plaques
I B
  • 10% or more of the skin is covered with patches or plaques
stage II
II A
  • Any amount of the skin is covered in patches or plaques
  • Lymph nodes are enlarged, but do not contain cancer
II B
  • There is one or more raised tumors on the skin
  • Lymph nodes may or may not be enlarged and do not contain cancer
stage III
III
  • Almost all of the skin is reddened
  • There may or may not be patches, plaques or skin tumors
  • Lymph nodes may or may not be enlarged and do not contain cancer
stage IV
IV A
  • Cancer has spread to the lymph nodes, but not to other organs in the body
IV B
  • Cancer has spread to other organs in the body, including the blood and bone marrow
  • Lymph nodes may be enlarged and may contain cancer

References

  1. Mycosis fungoides. Radiopaedia.http://radiopaedia.org/articles/mycosis-fungoides Accessed on January 20, 2016
  2. 2.0 2.1 2.2 Cutaneous T cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/cutaneous-t-cell-lymphoma/?region=on Accessed on January 19, 2016


Template:WikiDoc Sources